Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?

× No keyword cloud information.

10 in total

1. Drug persistency of two cholinesterase inhibitors: rivastigmine versus donepezil in elderly patients with Alzheimer's disease.

Authors: Dong-Churl Suh; Simu K Thomas; Elmira Valiyeva; Stephen Arcona; Lien Vo
Journal: Drugs Aging Date: 2005 Impact factor: 3.923

2. Safety and efficacy of rivastigmine in patients with Alzheimer's disease not responding adequately to donepezil: an open-label study.

Authors: Gary S Figiel; Carl H Sadowsky; John Strigas; Barbara Koumaras; Xiangyi Meng; Ibrahim Gunay
Journal: Prim Care Companion J Clin Psychiatry Date: 2008

Review 3. Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.

Authors: C Sadowsky; J A Davila Perez; R W Bouchard; I Goodman; S Tekin
Journal: CNS Neurosci Ther Date: 2010 Impact factor: 5.243

4. Long-term safety and tolerability of rivastigmine in patients with Alzheimer's disease switched from donepezil: an open-label extension study.

Authors: Gary S Figiel; Barbara Koumaras; Xiangyi Meng; John Strigas; Ibrahim Gunay
Journal: Prim Care Companion J Clin Psychiatry Date: 2008

5. Efficacy and safety of switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch in patients with probable Alzheimer's disease.

Authors: Hyun Jeong Han; Jeong Ju Lee; Sun A Park; Hyun Young Park; Jeong Eun Kim; Young Soo Shim; Dong-Seok Shim; Eun-Joo Kim; Soo Jin Yoon; Seong Hye Choi
Journal: J Clin Neurol Date: 2011-09-29 Impact factor: 3.077

6. Progress update: Pharmacological treatment of Alzheimer's disease.

Authors: David B Hogan
Journal: Neuropsychiatr Dis Treat Date: 2007 Impact factor: 2.570

7. Comparison of persistence rates of acetylcholine-esterase inhibitors in a state Medicaid program.

Authors: Susan M Abughosh; Stephen J Kogut
Journal: Patient Prefer Adherence Date: 2008-02-02 Impact factor: 2.711

8. Short term response is predictive of long term response to acetylcholinesterase inhibitors in Alzheimer's disease: a starting point to explore Bayesian approximation in clinical practice.

Authors: Eugenia Rota; Patrizia Ferrero; Rita Ursone; Giuseppe Migliaretti
Journal: Bioinformation Date: 2007-08-16

9. Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.

Authors: Gianfranco Spalletta; Carlo Caltagirone; Alessandro Padovani; Sandro Sorbi; Mahmood Attar; Delia Colombo; Luca Cravello
Journal: PLoS One Date: 2014-02-19 Impact factor: 3.240

10. Rapid neurobehavioural analysis based on the effects of an acetylcholinesterase inhibitor from Tephrosia purpurea in Zebrafish.

Authors: Rajesh Kannan Rajaretinam; Prakash Vincent Samuel Gnana
Journal: Ann Neurosci Date: 2012-01

10 in total